Clinical approach to the critically ill, morbidly obese patient

scientific article published on March 2004

Clinical approach to the critically ill, morbidly obese patient is …
instance of (P31):
scholarly articleQ13442814
review articleQ7318358

External links are
P356DOI10.1164/RCCM.200309-1256CC
P698PubMed publication ID14982823

P2093author name stringAli A El-Solh
P2860cites workMidazolamQ56386972
The use of the Body Mass Index in studies of abdominal wound infectionQ67515546
Postoperative chest percussion with postural drainage in obese patients following gastric staplingQ70671156
Facilitation of internal jugular venous cannulation using an audio-guided Doppler ultrasound vascular access device: results from a prospective, dual-center, randomized, crossover clinical studyQ71988735
Practice parameters for intravenous analgesia and sedation for adult patients in the intensive care unit: an executive summary. Society of Critical Care MedicineQ72034446
Role of radiologic contrast studies in the early postoperative period after bariatric surgeryQ73362798
Safety of bedside percutaneous dilatational tracheostomy in obese patients in the ICUQ73783559
Abdominal compartment syndromeQ77343119
Becaplermin gel in the treatment of pressure ulcers: a phase II randomized, double-blind, placebo-controlled studyQ78032732
Predictive models for difficult laryngoscopy and intubation. A clinical, radiologic and three-dimensional computer imaging studyQ78139647
The diagnostic approach to acute venous thromboembolism. Clinical practice guideline. American Thoracic SocietyQ78203203
Influence of extreme obesity on the body disposition and neuromuscular blocking effect of atracuriumQ28291227
Efficacy and safety of recombinant human activated protein C for severe sepsisQ29547839
Intensive insulin therapy in critically ill patientsQ29618795
Systematic reviews of wound care management: (5) beds; (6) compression; (7) laser therapy, therapeutic ultrasound, electrotherapy and electromagnetic therapy.Q30699672
Dermatological complications of obesityQ31104207
Dosing and monitoring of low-molecular-weight heparins in special populationsQ32049893
Sedation in the intensive care unitQ33884496
Effects of obesity on pharmacokinetics implications for drug therapyQ34053786
Obesity and the metabolic response to severe multiple trauma in manQ34177522
Use of propofol and other nonbenzodiazepine sedatives in the intensive care unitQ34474032
Acid aspiration prophylaxis in morbidly obese patients: famotidine vs. ranitidineQ34628794
Pressure ulcers in the chronically critically ill patientQ34761377
Critical care of the obese and bariatric surgical patientQ35104524
Principles and practices in the management of obesityQ35187875
Adaptation to the Intensive Care Environment (ATICE): Development and validation of a new sedation assessment instrumentQ35539695
Obesity: Nutrition Support Practice and Application to Critical CareQ40473506
Antimicrobial dosing in obese patientsQ41550525
Intravenous insulin nomogram improves blood glucose control in the critically ill.Q43730568
A comparison of two different prophylactic dose regimens of low molecular weight heparin in bariatric surgeryQ43898489
Validation study of two-microphone acoustic reflectometry for determination of breathing tube placement in 200 adult patientsQ44066265
The pharmacokinetics and pharmacodynamics of enoxaparin in obese volunteersQ44139059
Interventional radiologic placement of peripherally inserted central cathetersQ44189725
Permanent tracheostomy with cervical lipectomyQ44416860
Pharmacokinetic-pharmacodynamic analysis of drotrecogin alfa (activated) in patients with severe sepsisQ44487455
Risks and benefits of gastric bypass in morbidly obese patients with severe venous stasis diseaseQ44882541
Intra-abdominal pressure, sagittal abdominal diameter and obesity comorbidityQ45103043
Morbid obesity and tracheal intubationQ46075781
Prophylaxis of venous thromboembolism using two different doses of low-molecular-weight heparin (nadroparin) in bariatric surgery: a prospective randomized trialQ47195652
Pharmacokinetics of propofol during and after long-term continuous infusion for maintenance of sedation in ICU patientsQ47569947
1992 ARRS Executive Council Award. Detection of deep venous thrombosis: prospective comparison of MR imaging with contrast venographyQ48396656
Morbid obesity in the medical ICU.Q48676735
Daily interruption of sedative infusions in critically ill patients undergoing mechanical ventilation.Q51401261
Fentanyl inhibits metabolism of midazolam: competitive inhibition of CYP3A4 in vitro.Q51433312
Positive end-expiratory pressure improves respiratory function in obese but not in normal subjects during anesthesia and paralysis.Q51434538
Propofol decreases the clearance of midazolam by inhibiting CYP3A4: an in vivo and in vitro study.Q51444479
Effect of bi-level positive airway pressure (BiPAP) nasal ventilation on the postoperative pulmonary restrictive syndrome in obese patients undergoing gastroplasty.Q51546861
Hypocaloric enteral tube feeding in critically ill obese patients.Q51724916
Total respiratory system, lung, and chest wall mechanics in sedated-paralyzed postoperative morbidly obese patients.Q54154576
Controlled Sedation with Alphaxalone-AlphadoloneQ55061590
P433issue5
P407language of work or nameEnglishQ1860
P921main subjectpatientQ181600
obesityQ12174
P304page(s)557-561
P577publication date2004-03-01
P1433published inAmerican Journal of Respiratory and Critical Care MedicineQ4744267
P1476titleClinical approach to the critically ill, morbidly obese patient
P478volume169

Reverse relations

cites work (P2860)
Q36296487A comparative study of the complications of surgical tracheostomy in morbidly obese critically ill patients
Q37802492Acute Kidney Injury in the Critically Ill, Morbidly Obese Patient: Diagnostic and Therapeutic Challenges in a Unique Patient Population
Q37201598Analysis of morbidity, mortality, and risk factors of tracheostomy-related complications in patients with oral and maxillofacial cancer
Q34999349Arterial blood pressure monitoring in overweight critically ill patients: invasive or noninvasive?
Q36084489Best practice recommendations for anesthetic perioperative care and pain management in weight loss surgery
Q36331619Clinical and critical care concerns in severely ill obese patient
Q36903183Clinical characteristics, sepsis interventions and outcomes in the obese patients with septic shock: an international multicenter cohort study
Q47963698Critical care and obstructive sleep apnea
Q34400957Critical care in AJRCCM 2004.
Q38713104Disease-specific nutrition therapy: one size does not fit all.
Q22305425Epidemiology of severe sepsis
Q37317941Obesity and acute lung injury
Q30372291Obesity and the lung: 3. Obesity, respiration and intensive care.
Q99408733Postoperative Complications in Obese Patients After Tracheostomy
Q43522029Procoagulant and fibrinolytic activity in ventilator-associated pneumonia: impact of inadequate antimicrobial therapy
Q44928904Renal function in critically ill, morbidly obese patients
Q34481924Respiratory management of the obese patient undergoing surgery
Q33753363Separating wheat from chaff: examining the obesity paradox in the critically ill.
Q40179593Serum piperacillin/tazobactam pharmacokinetics in a morbidly obese individual
Q40148916The Effect of Morbid Obesity on Subarachnoid Hemorrhage Prognosis in the United States.

Search more.